RFQ.doc

DOC document 72 KB Posted

Attached to
Notice of Intent to Sole Source Illumina Corporation Inc.
Solicitation number
FDA-2014-SO-11235076
Issued by

About this file

The U. S Food Drug Administration Office of Acquisitions and Grants Services is requesting quotes to purchase a NextSeq High Output Reagents with Multiple Delivery Dates.

View the file

Other files

File Type Posted
Notice_of_Intent_to_Sole_Source.doc DOC document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

COMBINED SYNOPSIS/SOLICITATION – FDA-2014-SOL- 11235076.

Company Name/ADDRESS:

DUNS Number:

Subject: Request For Quote - “NextSeq™ 500 High Output Kit (300 cycles)”.

The U. S Food & Drug Administration, Office of Acquisitions and Grants Services is requesting quotes to purchase a “NextSeq High Output Reagents with Multiple Delivery Dates”.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, (STREAMLINED PROCEDURES FOR EVALUATION AND SOLICITATION FOR COMMERCIAL ITEMS) as supplemented with additional information included in this notice. This announcement constitutes the only solicitation.

This solicitation is issued as a Request For Quotations (RFQ), using the Simplified Acquisitions Procedures of FAR 13. The solicitation document/incorporated provisions and clauses are those in effect through the current Federal Acquisition Circular: FAC 2005 - 74.

The associated NAICS Code is: 334516 Analytical Laboratory Instrument Manufacturing. The Government intends to award a Firm Fixed-Price contract.

1) DESCRIPTION:

This RFQ is to purchase a “NextSeq™ 500 High Output Kit (300 cycles)”. The U.S. Food and Drug Administration, FDA/ CVM laboratory analyzes metagenome samples using NextSeq 500 sequencer. To support on-going genomic research at the Office of Research, sequencing reagents that work on the Illumina NextSeq 500 sequencing platform are required.

2) PRICING CHART:

All charges must be included in the quote. Any charges presented after contract award shall be unacceptable. The vendor must complete the pricing chart below.

Catalog Number
Description
Qty
Unit Price
Total Cost
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
5
$
$
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
6
$
$
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
5
$
$
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
4
$
$
Shipping/Insurance Cost
$
Grand Total Cost
$

3) SALIENT CHARACTERISTICS OF REQUESTED ITEMS: “NextSeq™ 500 High Output Kit (300 cycles)”.

· The requested item must be “NextSeq High Output Reagents with multiple delivery dates.

· FDA/CVM requires the above specific reagents which are compatible with CVM’s existing NextSeq 500 sequencing instrument manufactured by Illumina.

4) ADDITIONAL CONSIDERATIONS:

· Delivery of reagents must be made on the days specified in the delivery schedule and delivery location provided below in this RFQ.

· The delivered reagents need to have the furthest expiration date possible. For example, if a reagent’s shelf life is 6 months, the delivered reagents must have an expiration date of no less than 5 months out (6 months minus 30 days allowed for delivery).

· Delivery shall not be scheduled or occur on Federal Holidays or on days the Federal Government is closed due to inclement weather or other events.

Required Quantities and Delivery Date:

Cat #
Description
Qty
Delivery Date
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
5
7/9/2014
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
6
8/19/2014
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
5
9/17/2014
FC-404-1004
NextSeq™ 500 High Output Kit (300 cycles)
4
10/7/2014

5) CLAUSES: This solicitation incorporates the following clauses.

52.232-40 - Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)

(a) Upon receipt of accelerated payments from the Government, the Contractor shall make accelerated payments to its small business subcontractors under this contract, to the maximum extent practicable and prior to when such payment is otherwise required under the applicable contract or subcontract, after receipt of a proper invoice and all other required documentation from the small business subcontractor.

(b) The acceleration of payments under this clause does not provide any new rights under the Prompt Payment Act.

(c) Include the substance of this clause, including this paragraph (c), in all subcontracts with small business concerns, including subcontracts with small business concerns for the acquisition of commercial items.

6) CONTRACTING OFFICERS REPRESENTATIVE (COR):

· The COR assigned to this contract is responsible for maintaining the contract record, timely receiving of receipts, and for communicating with the Contracting Officer/Specialist to ensure the vendor is meeting the requirements of the contract. The designated COR for this contract will be determined at the time of award.

7) PACKING, MARKING, DELIVERY, SHIPPING AND INSTALLATION:

· At a minimum, all deliverables shall be marked with the Contract Number, the Contractor’s Name and delivered to the following address:

Food and Drug Administration (FDA)

8401 Muirkirk Road, (Mod 2) Room # 2405 Laurel, MD 20708.

8) RFQ INSTRUCTIONS:

The vendor must complete the Pricing Chart provided above in this RFQ. Responses shall have the following information:

- Identified with the RFQ number.

- The vendor’s current address and DUNS Number

- Responses shall be submitted to the Contract Specialist’s email below.

- Quotes must be for all the items requested or none.

- Quotes must remain valid until 09/30/2014.

- Response Due Date shall be no later than: 06/30/2014 at 12:00 pm EST.

EVALUATION AWARD CRITERIA

The Government shall award this contract to the Lowest Price Technically Acceptable (LPTA) Quote.

GENERAL INFORMATION

a. CONTRACTING POINT OF CONTACT:

Emmanuel T. Mbah

5630 Fishers Lane, Room 2142

Rockville MD 20857

Voice: 301.827.7156

Email: Emmanuel.mbah@fda.hhs.gov

File details come from the government source that posted it. Updated .